IMPACT OF MICROVASCULAR DISEASE ON CARDIORENAL OUTCOMES IN TYPE 2 DIABETES: AN ANALYSIS FROM THE LEADER AND SUSTAIN-6 CLINICAL TRIALS

被引：0
|
作者：
Verma, Subodh [1 ]
Bain, Stephen C. [1 ]
Honore, Julie Broe [1 ]
Mann, Johannes F. E. [1 ]
Nauck, Michael A. [1 ]
Pratley, Richard E. [1 ]
Rasmussen, Soren [1 ]
Ripa, Maria Sejersten [1 ]
Zinman, Bernard [1 ]
Buse, John [1 ]
机构：
[1] Novo Nordisk AS, Soborg, Denmark
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 73卷 / 09期
关键词：
D O I：
10.1016/S0735-1097(19)32293-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
911-04
引用
收藏
页码：1687 / 1687
页数：1
相关论文
共 50 条
  • [1] Impact of microvascular disease on cardiorenal outcomes in type 2 diabetes: an analysis from the LEADER and SUSTAIN 6 clinical trials
    Zinman, B.
    Verma, S.
    Bain, S. C.
    Honore, J. B.
    Mann, J.
    Nauck, M. A.
    Pratley, R.
    Rasmussen, S.
    Ripa, M. Sejersten
    Buse, J. B.
    [J]. DIABETOLOGIA, 2019, 62 : S365 - S366
  • [2] DURATION OF DIABETES AND CARDIORENAL EFFICACY OF LIRAGLUTIDE AND SEMAGLUTIDE: A POST HOC ANALYSIS OF THE LEADER AND SUSTAIN-6 CLINICAL TRIALS
    Verma, Subodh
    Bain, Stephen C.
    Honore, Julie Broe
    Fries, Tea Monk
    Nauck, Michael A.
    Pratley, Richard E.
    Rasmussen, Soren
    Zinman, Bernard
    Buse, John
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1704 - 1704
  • [3] Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN-6 cardiovascular outcomes trials
    Kahkoska, Anna R.
    Geybels, Milan S.
    Klein, Klara R.
    Kreiner, Frederik F.
    Marx, Nikolaus
    Nauck, Michael A.
    Pratley, Richard E.
    Wolthers, Benjamin O.
    Buse, John B.
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (09): : 1537 - 1547
  • [4] Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials
    Verma, Subodh
    Bain, Stephen C.
    Fries, Tea Monk
    Mazer, C. David
    Nauck, Michael A.
    Pratley, Richard E.
    Rasmussen, Soren
    Saevereid, Hans A.
    Zinman, Bernard
    Buse, John B.
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (07): : 1745 - 1751
  • [5] Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from theLEADERandSUSTAIN6 clinical trials
    Verma, Subodh
    Bain, Stephen C.
    Honore, Julie Broe
    Mann, Johannes F. E.
    Nauck, Michael A.
    Pratley, Richard E.
    Rasmussen, Soren
    Ripa, Maria Sejersten
    Zinman, Bernard
    Buse, John B.
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (11): : 2193 - 2198
  • [6] A LEADER in the management of type 2 diabetes and cardiorenal disease
    Verma, Subodh
    Leiter, Lawrence A.
    Latter, David A.
    Bhatt, Deepak L.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 159 (03): : 978 - 984
  • [7] The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials
    Zobel, Emilie H.
    von Scholten, Bernt Johan
    Hansen, Tine W.
    Persson, Frederik
    Rasmussen, Soren
    Wolthers, Benjamin
    Rossing, Peter
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (02): : 281 - 288
  • [8] THE IMPORTANCE OF ADDRESSING MULTIPLE RISK MARKERS IN TYPE 2 DIABETES: RESULTS FROM THE LEADER AND SUSTAIN 6 TRIALS
    Zobel, Emilie
    Von Scholten, Bernt Johan
    Hansen, Tine
    Persson, Frederik
    Rasmussen, Soren
    Wolthers, Benjamin
    Rossing, Peter
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [9] Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials
    Kaul, Sanjay
    [J]. DIABETES CARE, 2017, 40 (07) : 821 - 831
  • [10] Effects of once-weekly subcutaneous semaglutide on coronary artery disease outcomes in patients with type 2 diabetes with or at high risk for cardiovascular disease: Insights from the SUSTAIN-6 trial
    Kolkailah, Ahmed A.
    Lingvay, Ildiko
    Dobrecky-Mery, Idit
    Aharonovich, Alona
    David, Jens-Peter
    Holse, Cecilie
    Rasmussen, Soren
    McGuire, Darren K.
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 1117 - 1120
12345